Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06287593
What this trial is testing

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Zhejiang University 300
Early research (Phase 1)Looking for participantsNCT06566443
What this trial is testing

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
The Methodist Hospital Research Institute 15
Not applicableUnknownNCT01450553
What this trial is testing

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

Who this might be right for
Non-Small Cell Lung Cancer
Precision Therapeutics 450
Early research (Phase 1)Study completedNCT01854684
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIB Non-Small Cell Lung Carcinoma+2 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634
What this trial is testing

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

Who this might be right for
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07086326
What this trial is testing

A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC

Who this might be right for
NSCLCNeoadjuvant TherapyImmunotherapy+2 more
Yang Fan, MD 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06299371
What this trial is testing

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Who this might be right for
Non Small Cell Lung Cancer
Liaoning Cancer Hospital & Institute 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07807722
What this trial is testing

Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)EGFRNeoadjuvant Therapy
Hubei Cancer Hospital 29
Testing effectiveness (Phase 2)Ended earlyNCT00923949
What this trial is testing

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)UnknownNCT04304248
What this trial is testing

Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hao Long 30
Large-scale testing (Phase 3)Study completedNCT00003159
What this trial is testing

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medical Research Council 600
Testing effectiveness (Phase 2)UnknownNCT04108013
What this trial is testing

SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Who this might be right for
Lung Cancer Stage IIPD-1 AntibodyNon-small Cell Lung Cancer
Xuanwu Hospital, Beijing 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07608159
What this trial is testing

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Who this might be right for
Non Small Cell Lung CancerStereotactic Body RadiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Shanghai Pulmonary Hospital, Shanghai, China 201
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Large-scale testing (Phase 3)Study completedNCT04158440
What this trial is testing

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

Who this might be right for
Stage II-III Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 501
Testing effectiveness (Phase 2)Looking for participantsNCT06784791
What this trial is testing

Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)

Who this might be right for
Lung Cancer (NSCLC)
University Hospital, Essen 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379739
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 89
Not applicableUnknownNCT06081777
What this trial is testing

Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Peking University Cancer Hospital & Institute 65
Testing effectiveness (Phase 2)Looking for participantsNCT06008730
What this trial is testing

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell Carcinoma
Emory University 10
Testing effectiveness (Phase 2)Looking for participantsNCT04865250
What this trial is testing

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

Who this might be right for
NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB
University Hospital Heidelberg 20
Next Page